Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syndicate Bio is a platform-based biotechnology company focused on driving genomics-led drug discovery and precision medicine for diverse populations, with a primary focus on the African continent. The company partners with governments, pharmaceutical companies, and academic institutions to generate high-quality genomic data and insights from underrepresented populations. By bridging the gap in genomic diversity, Syndicate Bio aims to accelerate the development of therapeutics and diagnostics that are effective across global populations. Their business model centers on ethical data sourcing and collaborative research to address unmet medical needs in infectious diseases and oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VC syndicate.